Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints.
Honap S, Jairath V, Sands BE, Dulai PS, Higgins PDR, De Cruz P, Gutiérrez A, Kotze PG, Ye BD, Kobayashi T, Gearry RB, Olivera PA, Amiot A, Mosli MH, Al Awadhi S, Halfvarson J, Patel KV, Sebastian S, Danese S, Peyrin-Biroulet L. Honap S, et al. Among authors: mosli mh. Clin Gastroenterol Hepatol. 2024 Dec 15:S1542-3565(24)01082-6. doi: 10.1016/j.cgh.2024.10.029. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39681225 Free article.
Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.
Alkhatib NS, Almutairi AR, Almadi M, Halloush S, Al-Ruthia YSH, Rashdan O, Al-Shatnawi S, Azzam NA, Mosli MH, Badawoud AM, Al Yami MS, Alhossan A, AlHarbi I. Alkhatib NS, et al. Among authors: mosli mh. PLoS One. 2024 Nov 12;19(11):e0312603. doi: 10.1371/journal.pone.0312603. eCollection 2024. PLoS One. 2024. PMID: 39531466 Free PMC article.
The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group.
Azzam N, Alharbi O, Altuwaijri M, Alruthia Y, Alfarhan H, Alshankiti S, Nafisah F, Ajlan Q, Aljebreen A, Almadi M, Mosli MH. Azzam N, et al. Among authors: mosli mh. Saudi J Gastroenterol. 2025 Jan 1;31(1):34-40. doi: 10.4103/sjg.sjg_249_24. Epub 2024 Sep 19. Saudi J Gastroenterol. 2025. PMID: 39291466 Free article.
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents.
Saadah OI, AlAmeel T, Al Sarkhy A, Hasosah M, Al-Hussaini A, Almadi MA, Al-Bawardy B, Altuwaijri TA, AlEdreesi M, Bakkari SA, Alharbi OR, Azzam NA, Almutairdi A, Alenzi KA, Al-Omari BA, Almudaiheem HY, Al-Jedai AH, Mosli MH. Saadah OI, et al. Among authors: mosli mh. Saudi J Gastroenterol. 2024 Aug 30. doi: 10.4103/sjg.sjg_171_24. Online ahead of print. Saudi J Gastroenterol. 2024. PMID: 39215473 Free article.
Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy.
Azzam NA, Almutairdi A, Almudaiheem HY, AlAmeel T, Bakkari SA, Alharbi OR, Alenzi KA, AlMolaiki MA, Al-Omari BA, Albarakati RG, Al-Jedai AH, Saadah OI, Almadi MA, Al-Bawardy B, Mosli MH. Azzam NA, et al. Among authors: mosli mh. Saudi J Gastroenterol. 2023 Dec 15;30(4):181-97. doi: 10.4103/sjg.sjg_318_23. Online ahead of print. Saudi J Gastroenterol. 2023. PMID: 38099556 Free PMC article.
Rare variant burden analysis from exomes of three consanguineous families reveals LILRB1 and PRSS3 as potential key proteins in inflammatory bowel disease pathogenesis.
Jan RM, Al-Numan HH, Al-Twaty NH, Alrayes N, Alsufyani HA, Alaifan MA, Alhussaini BH, Shaik NA, Awan Z, Qari Y, Saadah OI, Banaganapalli B, Mosli MH, Elango R. Jan RM, et al. Among authors: mosli mh. Front Med (Lausanne). 2023 May 5;10:1164305. doi: 10.3389/fmed.2023.1164305. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37215724 Free PMC article.
61 results